Inherited disease susceptibility

MONDO:0020573

A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.

Also known as: hereditary disease susceptibility, hereditary predisposition to disease, genetic predisposition, genetic predispositions, genetic susceptibilities, genetic susceptibility, predisposition, genetic, predispositions, genetic

1316 clinical trials for this condition and its sub-types, 81 tagged with Inherited disease susceptibility itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Disease susceptibility (1319)

Sub-types of Inherited disease susceptibility

Hereditary neoplastic syndrome 60 trials · 731 incl. sub-types
117 sub-types
- Glioma susceptibility 0 trials · 133 incl. sub-types Sub-types →
- Neurofibromatosis 19 trials · 94 incl. sub-types Sub-types →
- Hereditary nonpolyposis colon cancer 5 trials · 88 incl. sub-types Sub-types →
- Multiple endocrine neoplasia 7 trials · 62 incl. sub-types Sub-types →
- Intestinal polyposis syndrome 3 trials · 53 incl. sub-types Sub-types →
- Tuberous sclerosis 41 trials · 44 incl. sub-types Sub-types →
- Leukemia, acute lymphocytic, susceptibility to, 1 41 trials
- BRCA2-related cancer predisposition 36 trials · 38 incl. sub-types Sub-types →
- Hereditary breast ovarian cancer syndrome 35 trials · 38 incl. sub-types Sub-types →
- Mismatch repair cancer syndrome 1 34 trials
- BRCA1-related cancer predisposition 23 trials · 27 incl. sub-types Sub-types →
- Nasopharyngeal carcinoma, susceptibility to, 1 21 trials
- Li-Fraumeni syndrome 16 trials
- PALB2-related cancer predisposition 14 trials Sub-types →
- Dyskeratosis congenita 12 trials Sub-types →
- Wiskott-Aldrich syndrome 10 trials
- PTEN hamartoma tumor syndrome 6 trials · 8 incl. sub-types Sub-types →
- Hereditary leiomyomatosis and renal cell cancer 8 trials
- CHEK2-related cancer predisposition 7 trials
- Susceptibility to familial cutaneous melanoma 0 trials · 7 incl. sub-types Sub-types →
- BAP1-related tumor predisposition syndrome 6 trials
- Beckwith-Wiedemann syndrome 6 trials Sub-types →
- RAD51C-related cancer predisposition 6 trials
- Hereditary pheochromocytoma-paraganglioma 6 trials Sub-types →
- Hereditary thrombocytopenia and hematologic cancer predisposition syndrome 1 trial · 5 incl. sub-types Sub-types →
- Nevoid basal cell carcinoma syndrome 5 trials Sub-types →
- RAD51D-related cancer predisposition 4 trials
- Kostmann syndrome 3 trials
- Li-fraumeni-like syndrome 3 trials
- Familial atypical multiple mole melanoma syndrome 3 trials Sub-types →
- Hereditary multiple osteochondromas 3 trials Sub-types →
- BARD1-related cancer predisposition 2 trials
- Brooke-Spiegler syndrome 0 trials · 2 incl. sub-types Sub-types →
- Maffucci syndrome 2 trials
- Blue rubber bleb nevus 2 trials
- Hereditary retinoblastoma 2 trials
- Inherited hematologic cancer-predisposing syndrome 2 trials
- Leukemia, chronic lymphocytic, susceptibility to, 2 2 trials
- Neuroblastoma, susceptibility to, 3 2 trials
- Rothmund-Thomson syndrome 1 trial Sub-types →
- SAMD9-related spectrum and myeloid neoplasm risk 1 trial
- SAMD9L-related spectrum and myeloid neoplasm risk 1 trial
- WAGR syndrome 1 trial Sub-types →
- Cherubism 1 trial Sub-types →
- Familial rhabdoid tumor 0 trials · 1 incl. sub-types Sub-types →
- Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors 1 trial
- Hyperparathyroidism 2 with jaw tumors 1 trial
- ATM-related cancer predisposition 0 trials
- CDH1-related diffuse gastric and lobular breast cancer syndrome 0 trials
- Carney-Stratakis syndrome 0 trials
- Cobb syndrome 0 trials
- DDX41-related hematologic malignancy predisposition syndrome 0 trials
- EGLN1-related erythrocytosis and pheochromocytoma/paraganglioma predisposition 0 trials
- GPR161-related medulloblastoma predisposition 0 trials
- HAVCR2-related cancer predisposition 0 trials
- Kaposi sarcoma, susceptibility to 0 trials
- N syndrome 0 trials
- NTHL1-deficiency tumor predisposition syndrome 0 trials
- Basal cell carcinoma, susceptibility to, 7 0 trials
- Breast cancer, familial, susceptibility to, 1 0 trials
- Breast cancer, familial, susceptibility to, 2 0 trials
- Breast cancer, familial, susceptibility to, 3 0 trials
- Cholangiocarcinoma, susceptibility to 0 trials
- Colorectal cancer, susceptibility to, 1 0 trials
- Colorectal cancer, susceptibility to, 10 0 trials
- Colorectal cancer, susceptibility to, 11 0 trials
- Colorectal cancer, susceptibility to, 12 0 trials
- Colorectal cancer, susceptibility to, 2 0 trials
- Colorectal cancer, susceptibility to, 3 0 trials
- Colorectal cancer, susceptibility to, 4 0 trials
- Colorectal cancer, susceptibility to, 5 0 trials
- Colorectal cancer, susceptibility to, 6 0 trials
- Colorectal cancer, susceptibility to, 7 0 trials
- Colorectal cancer, susceptibility to, 8 0 trials
- Colorectal cancer, susceptibility to, 9 0 trials
- Colorectal cancer, susceptibility to, on chromosome 15 0 trials
- Diffuse gastric and lobular breast cancer syndrome with or without cleft lip and/or palate 0 trials
- Erythroleukemia, familial, susceptibility to 0 trials
- Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome 0 trials
- Familial isolated hyperparathyroidism 0 trials Sub-types →
- Familial multiple fibrofolliculoma 0 trials
- Follicular lymphoma, susceptibility to 0 trials Sub-types →
- Hemangioma, capillary infantile, susceptibility to 0 trials
- Leukemia, acute lymphoblastic, susceptibility to, 3 0 trials
- Leukemia, acute lymphocytic, susceptibility to, 2 0 trials
- Leukemia, acute myeloid, susceptibility to 0 trials
- Leukemia, chronic lymphocytic, susceptibility to, 1 0 trials
- Leukemia, chronic lymphocytic, susceptibility to, 3 0 trials
- Leukemia, chronic lymphocytic, susceptibility to, 4 0 trials
- Leukemia, chronic lymphocytic, susceptibility to, 5 0 trials
- Lung cancer susceptibility 1 0 trials
- Lung cancer susceptibility 3 0 trials
- Lung cancer susceptibility 4 0 trials
- Lung cancer susceptibility 5 0 trials
- Melanoma and neural system tumor syndrome 0 trials
- Mosaic neurofibromatosis/schwannomatosis 0 trials Sub-types →
- Mosaic variegated aneuploidy syndrome 0 trials Sub-types →
- Multiple self-healing squamous epithelioma 0 trials
- Nasopharyngeal carcinoma, susceptibility to, 2 0 trials
- Nasopharyngeal carcinoma, susceptibility to, 3 0 trials
- Neuroblastoma, susceptibility to, 1 0 trials
- Neuroblastoma, susceptibility to, 2 0 trials
- Neuroblastoma, susceptibility to, 4 0 trials
- Neuroblastoma, susceptibility to, 5 0 trials
- Neuroblastoma, susceptibility to, 6 0 trials
- Neuroblastoma, susceptibility to, 7 0 trials
- Ovarian cancer, familial, susceptibility to, 1 0 trials
- Ovarian cancer, familial, susceptibility to, 2 0 trials
- Ovarian cancer, familial, susceptibility to, 3 0 trials
- Ovarian cancer, susceptibility to, 1 0 trials
- Pancreatic cancer, susceptibility to, 1 0 trials
- Pancreatic cancer, susceptibility to, 5 0 trials
- Progeroid features-hepatocellular carcinoma predisposition syndrome 0 trials
- Prostate cancer, hereditary, X-linked 3 0 trials
- Prostate cancer/brain cancer susceptibility 0 trials
- Susceptibility to uveal melanoma 0 trials Sub-types →
- Tumor predisposition syndrome 2 0 trials
Diabetes mellitus, insulin-dependent, X-linked, susceptibility to 0 trials · 178 incl. sub-types
21 sub-types
- Type 1 diabetes mellitus 1 146 trials
- Type 1 diabetes mellitus 12 26 trials
- Type 1 diabetes mellitus 2 6 trials
- Type 1 diabetes mellitus 10 1 trial
- Type 1 diabetes mellitus 11 0 trials
- Type 1 diabetes mellitus 13 0 trials
- Type 1 diabetes mellitus 15 0 trials
- Type 1 diabetes mellitus 17 0 trials
- Type 1 diabetes mellitus 18 0 trials
- Type 1 diabetes mellitus 19 0 trials
- Type 1 diabetes mellitus 20 0 trials
- Type 1 diabetes mellitus 21 0 trials
- Type 1 diabetes mellitus 22 0 trials
- Type 1 diabetes mellitus 23 0 trials
- Type 1 diabetes mellitus 24 0 trials
- Type 1 diabetes mellitus 3 0 trials
- Type 1 diabetes mellitus 4 0 trials
- Type 1 diabetes mellitus 5 0 trials
- Type 1 diabetes mellitus 6 0 trials
- Type 1 diabetes mellitus 7 0 trials
- Type 1 diabetes mellitus 8 0 trials
Lumbar disk herniation, susceptibility to 96 trials
Urinary tract infections, recurrent, susceptibility to 40 trials
Osteoarthritis susceptibility 6 37 trials
Pregnancy loss, recurrent, susceptibility 21 trials · 32 incl. sub-types
4 sub-types
- Pregnancy loss, recurrent, 4 14 trials
- Pregnancy loss, recurrent, susceptibility to, 1 11 trials
- Pregnancy loss, recurrent, susceptibility to, 2 0 trials
- Pregnancy loss, recurrent, susceptibility to, 3 0 trials
Osteoarthritis susceptibility 2 16 trials
IgA nephropathy, susceptibility to 0 trials · 16 incl. sub-types
3 sub-types
- IgA nephropathy, susceptibility to, 1 16 trials
- IgA nephropathy, susceptibility to, 2 0 trials
- IgA nephropathy, susceptibility to, 3 0 trials
Essential hypertension, genetic 14 trials
Osteoarthritis susceptibility 5 14 trials
Polysubstance abuse, susceptibility to 10 trials
Osteoarthritis susceptibility 1 8 trials
Autism, susceptiblity to 0 trials · 8 incl. sub-types
26 sub-types
- Autism, susceptibility to, X-linked 2 6 trials
- Autism, susceptibility to, 6 1 trial
- Intellectual developmental disorder with autism and speech delay 1 trial
- Autism, susceptibility to, 1 0 trials
- Autism, susceptibility to, 10 0 trials
- Autism, susceptibility to, 11 0 trials
- Autism, susceptibility to, 12 0 trials
- Autism, susceptibility to, 13 0 trials
- Autism, susceptibility to, 14a 0 trials
- Autism, susceptibility to, 14b 0 trials
- Autism, susceptibility to, 15 0 trials
- Autism, susceptibility to, 16 0 trials
- Autism, susceptibility to, 17 0 trials
- Autism, susceptibility to, 19 0 trials
- Autism, susceptibility to, 20 0 trials
- Autism, susceptibility to, 3 0 trials
- Autism, susceptibility to, 4 0 trials
- Autism, susceptibility to, 7 0 trials
- Autism, susceptibility to, 8 0 trials
- Autism, susceptibility to, 9 0 trials
- Autism, susceptibility to, X-linked 1 0 trials
- Autism, susceptibility to, X-linked 3 0 trials
- Autism, susceptibility to, X-linked 4 0 trials
- Autism, susceptibility to, X-linked 5 0 trials
- Epsilon-trimethyllysine hydroxylase deficiency 0 trials
- Intellectual developmental disorder with autism and macrocephaly 0 trials
Focal segmental glomerulosclerosis 4, susceptibility to 7 trials
GBA1-related Parkinson disease, susceptibility 6 trials
Neural tube defects, susceptibility to 6 trials
Otitis media, susceptibility to 5 trials
Pulmonary edema of mountaineers, susceptibility to 5 trials
Exfoliation syndrome, susceptibility to 4 trials
Pelvic organ prolapse, susceptibility to 4 trials
Inherited susceptibility to asthma 2 trials · 3 incl. sub-types
9 sub-types
- Asthma-related traits, susceptibility to, 4 1 trial
- Asthma, aspirin-induced, susceptibility to 0 trials
- Asthma-related traits, susceptibility to, 1 0 trials
- Asthma-related traits, susceptibility to, 2 0 trials
- Asthma-related traits, susceptibility to, 3 0 trials
- Asthma-related traits, susceptibility to, 5 0 trials
- Asthma-related traits, susceptibility to, 6 0 trials
- Asthma-related traits, susceptibility to, 7 0 trials
- Asthma-related traits, susceptibility to, 8 0 trials
Breast-ovarian cancer, familial, susceptibility to 0 trials · 3 incl. sub-types
5 sub-types
- Breast-ovarian cancer, familial, susceptibility to, 1 3 trials
- Breast-ovarian cancer, familial, susceptibility to, 2 2 trials
- Breast-ovarian cancer, familial, susceptibility to, 3 0 trials
- Breast-ovarian cancer, familial, susceptibility to, 4 0 trials
- Breast-ovarian cancer, familial, susceptibility to, 5 0 trials
Diabetes mellitus, ketosis-prone 2 trials
Microvascular complications of diabetes, susceptibility 2 trials
7 sub-types
Alzheimer disease 9 1 trial
Helicobacter pylori infection, susceptibility to 1 trial
UV-induced skin damage, susceptibility to 1 trial
Antisocial behavior, susceptibility to 1 trial
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial jak1 deficiency 1 trial
Coronary artery disease, severe, susceptibility to 1 trial
Familial meningioma 1 trial
Hearing loss, cisplatin-induced, susceptibility to 1 trial
Hemorrhage, intracerebral, susceptibility to 1 trial
Hepatic fibrosis, severe, susceptibility to, due to Schistosoma mansoni infection 1 trial
Hepatitis C virus, susceptibility to 1 trial
Inherited susceptibility to mycobacterial diseases 1 trial
14 sub-types
Nephrolithiasis, uric acid, susceptibility to 1 trial
Predisposition to invasive fungal disease due to CARD9 deficiency 1 trial
Tobacco addiction, susceptibility to 1 trial
Alzheimer disease, susceptibility to, mitochondrial 0 trials
Ascaris lumbricoides infection, susceptibility to 0 trials
Asperger syndrome, susceptibility to 0 trials
6 sub-types
- Asperger syndrome, X-linked, susceptibility to, 1 0 trials
- Asperger syndrome, X-linked, susceptibility to, 2 0 trials
- Asperger syndrome, susceptibility to, 1 0 trials
- Asperger syndrome, susceptibility to, 2 0 trials
- Asperger syndrome, susceptibility to, 3 0 trials
- Asperger syndrome, susceptibility to, 4 0 trials
Buruli ulcer, susceptibility to 0 trials
Graves disease, susceptibility to, 1 0 trials
Graves disease, susceptibility to, X-linked 2 0 trials
Hirschsprung disease, susceptibility to 0 trials
9 sub-types
- Hirschsprung disease, susceptibility to, 1 0 trials
- Hirschsprung disease, susceptibility to, 2 0 trials
- Hirschsprung disease, susceptibility to, 3 0 trials
- Hirschsprung disease, susceptibility to, 4 0 trials
- Hirschsprung disease, susceptibility to, 5 0 trials
- Hirschsprung disease, susceptibility to, 6 0 trials
- Hirschsprung disease, susceptibility to, 7 0 trials
- Hirschsprung disease, susceptibility to, 8 0 trials
- Hirschsprung disease, susceptibility to, 9 0 trials
Leber optic atrophy, susceptibility to 0 trials
Mycobacterium tuberculosis, susceptibility 0 trials
4 sub-types
- Mycobacterium tuberculosis, susceptibility to, 1 0 trials
- Mycobacterium tuberculosis, susceptibility to, 2 0 trials
- Mycobacterium tuberculosis, susceptibility to, 3 0 trials
- Mycobacterium tuberculosis, susceptibility to, X-linked 0 trials
Parkinson disease 11, autosomal dominant, susceptibility to 0 trials
Parkinson disease 13, autosomal dominant, susceptibility to 0 trials
Parkinson disease 18, autosomal dominant, susceptibility to 0 trials
Parkinson disease 24, autosomal dominant, susceptibility to 0 trials
Parkinson disease 26, autosomal dominant, susceptibility to 0 trials
Parkinson disease 5, autosomal dominant, susceptibility to 0 trials
SH2B3-related immune system disorder 0 trials
Schistosoma mansoni infection, susceptibility/resistance to 0 trials
West Nile virus, susceptibility to 0 trials
Age related macular degeneration, susceptibility to 0 trials
3 sub-types
- Age related macular degeneration 13 0 trials
- Age related macular degeneration 15 0 trials
- Age related macular degeneration 5 0 trials
Allergic rhinitis, susceptibility to 0 trials
Amyotrophic lateral sclerosis, susceptibility to, 13 0 trials
Amyotrophic lateral sclerosis, susceptibility to, 24 0 trials
Amyotrophic lateral sclerosis, susceptibility to, 25 0 trials
Anorexia nervosa, susceptibility to, 1 0 trials
Aortic aneurysm, familial thoracic 11, susceptibility to 0 trials
Aplastic anemia, susceptibility to 0 trials
Appendicitis, proneness to 0 trials
Aspergillosis, susceptibility to 0 trials
Atherosclerosis susceptibility 0 trials
Atrioventricular septal defect, susceptibility to, 1 0 trials
Atrioventricular septal defect, susceptibility to, 2 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 1 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 2 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 3 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 4 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 5 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 6 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 7 0 trials
Autoimmune disease, susceptibility to, 1 0 trials
Autoimmune disease, susceptibility to, 2 0 trials
Autoimmune disease, susceptibility to, 3 0 trials
Autoimmune disease, susceptibility to, 4 0 trials
Autoimmune disease, susceptibility to, 5 0 trials
Autoimmune disease, susceptibility to, 6 0 trials
Autoimmune thyroid disease, susceptibility to 0 trials
6 sub-types
- Graves disease, susceptibility to, 2 0 trials
- Graves disease, susceptibility to, X-linked 1 0 trials
- Autoimmune thyroid disease, susceptibility to, 1 0 trials
- Autoimmune thyroid disease, susceptibility to, 2 0 trials
- Autoimmune thyroid disease, susceptibility to, 3 0 trials
- Autoimmune thyroid disease, susceptibility to, 4 0 trials
Autoimmune thyroid disease, susceptibility to, 5 0 trials
Autosomal recessive Mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency 0 trials
Autosomal recessive Mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency 0 trials
Bacteremia, susceptibility 0 trials
2 sub-types
- Bacteremia, susceptibility to, 1 0 trials
- Bacteremia, susceptibility to, 2 0 trials
Basal cell carcinoma, susceptibility to 0 trials
7 sub-types
- Basal cell carcinoma, susceptibility to, 1 0 trials
- Basal cell carcinoma, susceptibility to, 2 0 trials
- Basal cell carcinoma, susceptibility to, 3 0 trials
- Basal cell carcinoma, susceptibility to, 4 0 trials
- Basal cell carcinoma, susceptibility to, 5 0 trials
- Basal cell carcinoma, susceptibility to, 6 0 trials
- Basal cell carcinoma, susceptibility to, 7 0 trials
Bleeding disorder, platelet-type, 13, susceptibility to 0 trials
Blepharospasm, benign essential, susceptibility to 0 trials
Bulimia nervosa, susceptibility to, 1 0 trials
Cardiomyopathy, familial hypertrophic, 4, susceptibility to 0 trials
Celiac disease, susceptibility to, 1 0 trials
Celiac disease, susceptibility to, 10 0 trials
Celiac disease, susceptibility to, 11 0 trials
Celiac disease, susceptibility to, 12 0 trials
Celiac disease, susceptibility to, 13 0 trials
Celiac disease, susceptibility to, 2 0 trials
Celiac disease, susceptibility to, 3 0 trials
Celiac disease, susceptibility to, 4 0 trials
Celiac disease, susceptibility to, 5 0 trials
Celiac disease, susceptibility to, 6 0 trials
Celiac disease, susceptibility to, 7 0 trials
Celiac disease, susceptibility to, 8 0 trials
Celiac disease, susceptibility to, 9 0 trials
Chronic mountain sickness, susceptibility to 0 trials
Cirrhosis, noncryptogenic, susceptibility to 0 trials
Coronary heart disease, susceptibility to, 1 0 trials
Coronary heart disease, susceptibility to, 2 0 trials
Coronary heart disease, susceptibility to, 3 0 trials
Coronary heart disease, susceptibility to, 4 0 trials
Coronary heart disease, susceptibility to, 5 0 trials
Coronary heart disease, susceptibility to, 6 0 trials
Coronary heart disease, susceptibility to, 7 0 trials
Coronary heart disease, susceptibility to, 8 0 trials
Coronary heart disease, susceptibility to, 9 0 trials
Craniosynostosis 5, susceptibility to 0 trials
Craniosynostosis 7 0 trials
Delayed sleep phase syndrome, susceptibility to 0 trials
Dengue fever, susceptibility to 0 trials
Dengue hemorrhagic fever, susceptibility to 0 trials
Dengue shock syndrome, susceptibility to 0 trials
Dengue virus, susceptibility to 0 trials
Dermatitis, atopic, susceptibility to 0 trials
9 sub-types
- Dermatitis, atopic, 1 0 trials
- Dermatitis, atopic, 2 0 trials
- Dermatitis, atopic, 3 0 trials
- Dermatitis, atopic, 4 0 trials
- Dermatitis, atopic, 5 0 trials
- Dermatitis, atopic, 6 0 trials
- Dermatitis, atopic, 7 0 trials
- Dermatitis, atopic, 8 0 trials
- Dermatitis, atopic, 9 0 trials
Dyslexia, susceptibility to, 1 0 trials
Dyslexia, susceptibility to, 2 0 trials
Dyslexia, susceptibility to, 3 0 trials
Dyslexia, susceptibility to, 4 0 trials
Dyslexia, susceptibility to, 5 0 trials
Dyslexia, susceptibility to, 6 0 trials
Dyslexia, susceptibility to, 7 0 trials
Dyslexia, susceptibility to, 8 0 trials
Dyslexia, susceptibility to, 9 0 trials
Dystonia 38, susceptibility to 0 trials
Efavirenz central nervous system toxicity, susceptibility to 0 trials
Encephalitis, acute, infection-induced, susceptibility to 0 trials
7 sub-types
Endometriosis, susceptibility to, 1 0 trials
Epidermodysplasia verruciformis, susceptibility to 0 trials
5 sub-types
- Epidermodysplasia verruciformis, susceptibility to, 1 0 trials
- Epidermodysplasia verruciformis, susceptibility to, 2 0 trials
- Epidermodysplasia verruciformis, susceptibility to, 3 0 trials
- Epidermodysplasia verruciformis, susceptibility to, 4 0 trials
- Epidermodysplasia verruciformis, susceptibility to, 5 0 trials
Epilepsy, childhood absence, susceptibility to, 1 0 trials
Epilepsy, childhood absence, susceptibility to, 5 0 trials
Epilepsy, childhood absence, susceptibility to, 6 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 1 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 10 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 12 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 13 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 14 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 15 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 16 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 17 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 18 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 19 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 2 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 3 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 4 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 5 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 6 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 7 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 8 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 9 0 trials
Epilepsy, juvenile absence, susceptibility to 0 trials
2 sub-types
- Epilepsy, idiopathic generalized, susceptibility to, 11 0 trials
- Epilepsy, juvenile absence, susceptibility to, 1 0 trials
Epilepsy, juvenile myoclonic, susceptibility to, 10 0 trials
Epilepsy, juvenile myoclonic, susceptibility to, 6 0 trials
Epilepsy, juvenile myoclonic, susceptibility to, 9 0 trials
Fatty liver disease, nonalcoholic, susceptibility to, 2 0 trials
Focal segmental glomerulosclerosis 3, susceptibility to 0 trials
Gallbladder disease 4 0 trials
Glaucoma, normal tension, susceptibility to 0 trials
Graft-versus-host disease, susceptibility to 0 trials
Hearing loss, noise-induced, susceptibility to 0 trials
Hemolytic uremic syndrome, atypical, susceptibility to, 1 0 trials
2 sub-types
- Atypical hemolytic-uremic syndrome with H factor anomaly 0 trials
- Atypical hemolytic-uremic syndrome with anti-factor H antibodies 0 trials
Hemolytic uremic syndrome, atypical, susceptibility to, 7 0 trials
Hepatitis B virus, susceptibility to 0 trials
Hepatitis, fulminant viral, susceptibility to 0 trials
Herpes simplex encephalitis, susceptibility to, 1 0 trials
Herpes simplex encephalitis, susceptibility to, 2 0 trials
Herpes simplex encephalitis, susceptibility to, 3 0 trials
Herpes simplex encephalitis, susceptibility to, 4 0 trials
Herpes simplex encephalitis, susceptibility to, 7 0 trials
Human herpesvirus 8, susceptibility to 0 trials
Hydrocephalus, congenital, 5, susceptibility to 0 trials
Hyperemesis gravidarum, susceptibility to 0 trials
Hyperlipidemia, combined, 1 0 trials
Hypertension, essential, susceptibility to, 1 0 trials
Hypertension, essential, susceptibility to, 2 0 trials
Hypertension, essential, susceptibility to, 3 0 trials
Hypertension, essential, susceptibility to, 4 0 trials
Hypertension, essential, susceptibility to, 5 0 trials
Hypertension, essential, susceptibility to, 6 0 trials
Hypertension, essential, susceptibility to, 7 0 trials
Hypertension, essential, susceptibility to, 8 0 trials
Hypervitaminosis a, susceptibility to 0 trials
Influenza, severe, susceptibility to 0 trials
Iron overload, susceptibility to 0 trials
Kuru, susceptibility to 0 trials
Legionnaire disease, susceptibility to 0 trials
Leishmaniasis, tegumentary, susceptibility to 0 trials
Leprosy, susceptibility to, 1 0 trials
Leprosy, susceptibility to, 2 0 trials
Leprosy, susceptibility to, 3 0 trials
Leprosy, susceptibility to, 4 0 trials
Leprosy, susceptibility to, 5 0 trials
Leprosy, susceptibility to, 6 0 trials
Lipodystrophy, partial, acquired, susceptibility to 0 trials
Lumbar disk degeneration, susceptibility to 0 trials
Major depressive disorder 1 0 trials
Major depressive disorder 2 0 trials
Malaria, susceptibility to 0 trials
1 sub-type
- Malaria, mild, susceptibility to 0 trials
Malignant hyperthermia, susceptibility to 0 trials
6 sub-types
- Malignant hyperthermia, susceptibility to, 1 0 trials
- Malignant hyperthermia, susceptibility to, 2 0 trials
- Malignant hyperthermia, susceptibility to, 3 0 trials
- Malignant hyperthermia, susceptibility to, 4 0 trials
- Malignant hyperthermia, susceptibility to, 5 0 trials
- Malignant hyperthermia, susceptibility to, 6 0 trials
Melioidosis, susceptibility to 0 trials
Migraine with or without aura, susceptibility to 0 trials
13 sub-types
- Migraine with aura, susceptibility to, 7 0 trials
- Migraine with aura, susceptibility to, 9 0 trials
- Migraine with or without aura, susceptibility to, 1 0 trials
- Migraine with or without aura, susceptibility to, 10 0 trials
- Migraine with or without aura, susceptibility to, 11 0 trials
- Migraine with or without aura, susceptibility to, 12 0 trials
- Migraine with or without aura, susceptibility to, 3 0 trials
- Migraine with or without aura, susceptibility to, 5 0 trials
- Migraine with or without aura, susceptibility to, 6 0 trials
- Migraine with or without aura, susceptibility to, 8 0 trials
- Migraine without aura, susceptibility to, 4 0 trials
- Migraine, familial typical, susceptibility to, 2 0 trials
- Migraine, with or without aura, susceptibility to, 13 0 trials
Multicentric Castleman disease, susceptibility to 0 trials
Multiple sclerosis, susceptibility to 0 trials
5 sub-types
- Multiple sclerosis, susceptibility to 1 0 trials
- Multiple sclerosis, susceptibility to, 2 0 trials
- Multiple sclerosis, susceptibility to, 3 0 trials
- Multiple sclerosis, susceptibility to, 4 0 trials
- Multiple sclerosis, susceptibility to, 5 0 trials
Multiple system atrophy 1, susceptibility to 0 trials
Myocardial infarction, susceptibility to 0 trials
Myocardial infarction, susceptibility to, 2 0 trials
Myoclonic epilepsy, juvenile, susceptibility to, 1 0 trials
Myoclonic epilepsy, juvenile, susceptibility to, 3 0 trials
Myoclonic epilepsy, juvenile, susceptibility to, 4 0 trials
Narcolepsy, susceptibility to 0 trials
4 sub-types
- Narcolepsy 2, susceptibility to 0 trials
- Narcolepsy 4, susceptibility to 0 trials
- Narcolepsy 5, susceptibility to 0 trials
- Narcolepsy 6, susceptibility to 0 trials
Nephrolithiasis susceptibility caused by SLC26A1 0 trials
Nonarteritic anterior ischemic optic neuropathy, susceptibility to 0 trials
Obesity, susceptibility to 0 trials
Opioid dependence, susceptibility to, 1 0 trials
Orofacial cleft 6, susceptibility to 0 trials
Osteoarthritis susceptibility 3 0 trials
Osteoarthritis susceptibility 4 0 trials
Pelvic organ prolapse, susceptibility to, 1 0 trials
Pelvic organ prolapse, susceptibility to, 2 0 trials
Peripartum cardiomyopathy, susceptibility to 0 trials
Podoconiosis, susceptibility to 0 trials
Polycystic kidney disease 9, susceptibility to 0 trials
Psoriasis, susceptibility to 0 trials
13 sub-types
- Psoriasis 1, susceptibility to 0 trials
- Psoriasis 10, susceptibility to 0 trials
- Psoriasis 11, susceptibility to 0 trials
- Psoriasis 12, susceptibility to 0 trials
- Psoriasis 13, susceptibility to 0 trials
- Psoriasis 15, pustular, susceptibility to 0 trials
- Psoriasis 3, susceptibility to 0 trials
- Psoriasis 4, susceptibility to 0 trials
- Psoriasis 5, susceptibility to 0 trials
- Psoriasis 6, susceptibility to 0 trials
- Psoriasis 7, susceptibility to 0 trials
- Psoriasis 8, susceptibility to 0 trials
- Psoriasis 9, susceptibility to 0 trials
Psoriatic arthritis, susceptibility to 0 trials
1 sub-type
- Psoriatic arthritis, susceptibility to, 1 0 trials
Pulmonary disease, chronic obstructive, susceptibility to 0 trials
Pulmonary hypertension, neonatal, susceptibility to 0 trials
Radioulnar synostosis, nonsyndromic, susceptibility to 0 trials
Renal dysplasia, cystic, susceptibility to 0 trials
Restless legs syndrome, susceptibility to 0 trials
8 sub-types
- Restless legs syndrome, susceptibility to, 1 0 trials
- Restless legs syndrome, susceptibility to, 2 0 trials
- Restless legs syndrome, susceptibility to, 3 0 trials
- Restless legs syndrome, susceptibility to, 4 0 trials
- Restless legs syndrome, susceptibility to, 5 0 trials
- Restless legs syndrome, susceptibility to, 6 0 trials
- Restless legs syndrome, susceptibility to, 7 0 trials
- Restless legs syndrome, susceptibility to, 8 0 trials
Rhabdomyolysis, susceptibility to 0 trials
2 sub-types
- Rhabdomyolysis, susceptibility to, 1 0 trials
- Rhabdomyolysis, susceptibility to, 2 0 trials
Sarcoidosis, susceptibility to, 1 0 trials
Sarcoidosis, susceptibility to, 2 0 trials
Sarcoidosis, susceptibility to, 3 0 trials
Schizophrenia, susceptibility to 0 trials
6 sub-types
- Schizophrenia 13 0 trials
- Schizophrenia 14 0 trials
- Schizophrenia 18 0 trials
- Schizophrenia 4 0 trials
- Schizophrenia 6 0 trials
- Schizophrenia 9 0 trials
Scoliosis, isolated, susceptibility to 0 trials
6 sub-types
- Scoliosis, isolated, susceptibility to, 1 0 trials
- Scoliosis, isolated, susceptibility to, 2 0 trials
- Scoliosis, isolated, susceptibility to, 3 0 trials
- Scoliosis, isolated, susceptibility to, 4 0 trials
- Scoliosis, isolated, susceptibility to, 5 0 trials
- Scoliosis, isolated, susceptibility to, 6 0 trials
Seasonal affective disorder, susceptibility to 0 trials
Sick sinus syndrome 3, susceptibility to 0 trials
Spondyloarthropathy, susceptibility to 0 trials
3 sub-types
- Spondyloarthropathy, susceptibility to, 1 0 trials
- Spondyloarthropathy, susceptibility to, 2 0 trials
- Spondyloarthropathy, susceptibility to, 3 0 trials
Strabismus, susceptibility to 0 trials
1 sub-type
- Strabismus, susceptibility to, 1 0 trials
Stroke, susceptibility to, 1 0 trials
Susceptibility to HIV infection 0 trials
Susceptibility to angioedema induced by ACE inhibitors 0 trials
Susceptibility to localized juvenile periodontitis 0 trials
Susceptibility to mononeuropathy of the median nerve, mild 0 trials
Susceptibility to respiratory infections associated with CD8alpha chain mutation 0 trials
Susceptibility to visceral leishmaniasis, 1 0 trials
Susceptibility to visceral leishmaniasis, 2 0 trials
Susceptibility to visceral leishmaniasis, 3 0 trials
Systemic lupus erythematosus with hemolytic anemia, susceptibility to, 1 0 trials
Systemic lupus erythematosus with nephritis, susceptibility to, 1 0 trials
Systemic lupus erythematosus with nephritis, susceptibility to, 2 0 trials
Systemic lupus erythematosus with nephritis, susceptibility to, 3 0 trials
Systemic lupus erythematosus, susceptibility to, 1 0 trials
Systemic lupus erythematosus, susceptibility to, 10 0 trials
Systemic lupus erythematosus, susceptibility to, 11 0 trials
Systemic lupus erythematosus, susceptibility to, 12 0 trials
Systemic lupus erythematosus, susceptibility to, 13 0 trials
Systemic lupus erythematosus, susceptibility to, 14 0 trials
Systemic lupus erythematosus, susceptibility to, 15 0 trials
Systemic lupus erythematosus, susceptibility to, 2 0 trials
Systemic lupus erythematosus, susceptibility to, 3 0 trials
Systemic lupus erythematosus, susceptibility to, 4 0 trials
Systemic lupus erythematosus, susceptibility to, 5 0 trials
Systemic lupus erythematosus, susceptibility to, 6 0 trials
Systemic lupus erythematosus, susceptibility to, 7 0 trials
Systemic lupus erythematosus, susceptibility to, 8 0 trials
Systemic lupus erythematosus, susceptibility to, 9 0 trials
Thyrotoxic periodic paralysis, susceptibility to, 1 0 trials
Thyrotoxic periodic paralysis, susceptibility to, 2 0 trials
Thyrotoxic periodic paralysis, susceptibility to, 3 0 trials
Ventricular fibrillation during myocardial infarction, susceptibility to 0 trials
Vitiligo-associated multiple autoimmune disease susceptibility 1 0 trials
Vitiligo-associated multiple autoimmune disease susceptibility 6 0 trials
Xanthomatosis, susceptibility to 0 trials

Most studied deeper sub-types

Glioma susceptibility 1 (133) Lynch syndrome (81) Neurofibromatosis type 1 (73) Multiple endocrine neoplasia type 1 (34) Classic familial adenomatous polyposis (33) Tuberous sclerosis 1 (33) Familial medullary thyroid carcinoma (23) NF2-related schwannomatosis (21) Peutz-Jeghers syndrome (9) Melanoma, cutaneous malignant, susceptibility to, 2 (6) Hereditary mixed polyposis syndrome (5) Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 (5) Juvenile polyposis syndrome (5) Lynch syndrome 1 (5) Multiple endocrine neoplasia type 2 (4) Multiple endocrine neoplasia type 2A (4) Attenuated familial adenomatous polyposis (3) Hoyeraal-Hreidarsson syndrome (3) Lynch syndrome 2 (3) Schwannomatosis (3)

Including sub-types (1316) Tagged with Inherited disease susceptibility (81)

Trials to join now! 40 Not yet recruiting 5 Not yet finished but already full! 19 Completed 17

Inherited disease susceptibility

Where it sits in the disease tree

Most studied deeper sub-types

Hidden scar breast reconstruction: endoscopic technique spares muscle

Fitbit and DNA test team up to fight diabetes in At-Risk asians

Brain scans and pain tests may foretell chronic pain after hysterectomy

Heart study volunteers get their genetic secrets back

Gene mutation may amplify cognitive risks of brain stimulation in Parkinson's

Digital tool helps families navigate Kids' cancer risk

Could your DNA predict thyroid cancer after radiation?

Could your surroundings trigger a hidden genetic risk?

Texts and nudges may help more people get cancer genetic testing

New study maps developmental milestones in babies with rare genetic conditions

Gene link to ICU blood sugar problems found

Gene test may unlock hypnosis power for pain relief

Cannabis study reveals hidden brain risks in asian users

Should all healthy newborns get their DNA screened? study investigates

Phone Check-Ins track prostate cancer in men with BRCA mutations

New study reveals how personalized breast cancer risk news impacts Women's emotions

PET scans may guide treatment of hidden fungal infection in cancer patients